New heart procedure tested against leading device in 466-patient trial
NCT ID NCT07523750
First seen Apr 14, 2026 · Last updated May 14, 2026 · Updated 5 times
Summary
This study compares a new catheter (VARIPULSE) to an approved one (FARAWAVE) for treating persistent atrial fibrillation, a condition where the heart beats irregularly for over a week. About 466 adults with this condition will be randomly assigned to one of the two procedures. The goal is to see which device is safer and more effective at restoring normal heart rhythm and improving quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Arrhythmia Research Group
RECRUITINGJonesboro, Arkansas, 72401, United States
Conditions
Explore the condition pages connected to this study.